Captrust Financial Advisors Pa Vmed Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.16 - $2.5 $1,963 - $4,232	1,693 Added 77.91%	3,866 $5,000
Q4 2021 Feb 14, 2022	SELL	$2.46 - $8.74 $34 - $122	-14 Reduced 0.64%	2,173 $5,000
Q3 2021 Nov 16, 2021	BUY	$5.1 - $9.39 $9,786 - $18,019	1,919 Added 716.04%	2,187 $19,000
Q2 2021 Aug 16, 2021	BUY	$3.95 - $6.88 $1,058 - $1,843	268 New	268 $2,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.